Skip to main content
ROIV
NASDAQ Life Sciences

QVT Financial LP Sells $49.3M in Roivant Shares Amidst Insider Distribution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$35.39
Mkt Cap
$25.455B
52W Low
$10.705
52W High
$35.9
52W Position info
231% above low
Off High info
1.4% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ROIV has more than doubled off its 52-week low of $10.705.

Summary

QVT Financial LP, an entity with a deputized director, sold over $49 million worth of Roivant Sciences shares, contributing to a broader pattern of insider distribution.


Key Events · Ownership and Investor Activity · ROIV

  • Significant Insider Sale

    QVT Financial LP, an entity with a deputized director, disposed of 1,438,163 common shares for a total of $49,354,076.

  • Ongoing Insider Distribution

    This sale follows recent dispositions by the CEO ($8.4M) and President/CIO ($34M), indicating a sustained pattern of insider selling.

  • Trading Near 52-Week Highs

    The sales occurred between June 26 and June 30, 2026, while Roivant Sciences' stock is trading near its 52-week high.


Analysis · ROIV · Life Sciences

This Form 4 filing reveals a substantial sale of Roivant Sciences shares by QVT Financial LP, an entity with significant influence through a deputized director. The nearly $50 million disposition adds to a recent trend of insider selling, including notable sales by the CEO and President/CIO. While the stock is trading near its 52-week high, suggesting profit-taking, the cumulative insider distribution could be interpreted as a lack of conviction in further upside or a strategic rebalancing of large positions.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ROIV was trading at $35.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $25.5B. The 52-week trading range was $10.71 to $35.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ROIV - Latest Insights

ROIV
Nov 09, 2026, 7:36 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $41.37
Real-time Price: $40.50 info
Change: -$0.870 (-2%) info
Market Cap: $29.254B info
ROIV
Nov 09, 2026, 7:17 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.00
Real-time Price: $40.50 info
Change: -$0.500 (-1%) info
Market Cap: $29.254B info
ROIV
Nov 09, 2026, 7:01 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $40.39
Real-time Price: $40.50 info
Change: +$0.110 (+0.27%) info
Market Cap: $29.254B info
ROIV
Oct 21, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $36.20
Real-time Price: $40.50 info
Change: +$4.30 (+12%) info
Market Cap: $29.254B info
ROIV
Oct 21, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $36.60
Real-time Price: $40.50 info
Change: +$3.90 (+11%) info
Market Cap: $29.254B info